Parallel Advisors’s Renalytix plc American Depositary Shares RNLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-60
Closed -$52 3449
2024
Q1
$52 Hold
60
﹤0.01% 3232
2023
Q4
$23 Buy
+60
New +$48 ﹤0.01% 3273

Other funds holding RNLX

Parallel Advisors's RNLX Position: Q2 2024 in Review

Parallel Advisors sold out of Renalytix plc American Depositary Shares (RNLX) in Q2 2024, closing a stake of 60 shares — an estimated $52 sold.

Parallel Advisors first reported a position in RNLX in Q4 2023 and held it in 2 quarters. The position peaked at $52 in Q1 2024. 26 funds tracked by Wall St. Rank hold RNLX as of Q2 2024.

  • Parallel Advisors reported no remaining Renalytix plc American Depositary Shares position as of Q2 2024 after selling out during the quarter.
  • Parallel Advisors sold 60 Renalytix plc American Depositary Shares shares in Q2 2024, an estimated $52.
  • Parallel Advisors first reported a position in Renalytix plc American Depositary Shares in Q4 2023 and held it in 2 quarters.
  • Parallel Advisors's Renalytix plc American Depositary Shares position peaked at $52 in Q1 2024.
  • 26 funds tracked by Wall St. Rank held Renalytix plc American Depositary Shares as of Q2 2024.

Based on Parallel Advisors's 13F filing for Q2 2024, filed 8 Aug 2024.